On Friday, Shares of Microsoft Corporation (NASDAQ:MSFT), gained 0.07% to $43.94.
Microsoft Corporation declared a new commitment of $70 million in community investments over the next three years to improvement access to computer science education for all youth, and especially for those from under-represented backgrounds. Through the company’s global YouthSpark initiative, scores of nonprofit organizations around the world will receive cash donations and other resources to provide computer science education to diverse populations of young people in their communities and prepare them with the computational-thinking and problem-solving skills necessary for success in an increasingly digital world.
Over the next three years, Microsoft will deliver on this commitment through cash grants and nonprofit partnerships in addition to unique program and content offerings to improvement access to computer science education and build computational thinking skills for diverse populations of youth. One of the flagship programs is Technology Education and Literacy in Schools (TEALS), which pairs tech professionals from across the industry with classroom educators to team-teach computer science in U.S. high schools. TEALS aims to grow fivefold in the next three years, with the aim of working with 2,000 tech industry volunteers to reach 30,000 students in nearly 700 schools across 33 states. A key objective of TEALS is to support classroom educators as they learn the computer science coursework, preparing them to teach computer science independently after two years of team-teaching.
Nadella reinforced the company’s commitment to computer science education recently during the annual Dreamforce conference hosted by Salesforce where he called upon thousands of tech professionals to serve as TEALS volunteers and assist broaden the opportunity for students of all backgrounds to learn computer science in high school.
Microsoft Corporation is engaged in developing, licensing and supporting a range of software products and services. The Company also designs and sells hardware, and delivers online advertising to the customers.
Shares of Marathon Oil Corporation (NYSE:MRO), inclined 1.91% to $15.74, during its last trading session.
Marathon Oil Corporation declared it plans to issue its third quarter 2015 earnings news release on Wednesday, Nov. 4, after the close of U.S. financial markets.
Prepared remarks together with accompanying slides will be available on the Company’s website about one hour after the earnings news release is issued. The Company will conduct a question-and-answer conference call, which will be webcast live, on Thursday, Nov. 5, at 9 a.m. EST.
Chris Phillips and Zach Dailey, co-directors of Investor Relations, will host the call. Also participating from Marathon Oil will be Lee M. Tillman, president and CEO; John R. (J.R.) Sult, executive vice president and chief financial officer; T. M. (Mitch) Little, vice president, International and Offshore Exploration and Production Operations; and Lance W. Robertson, vice president, North America Production Operations.
Marathon Oil Corporation is an energy company based in Houston, Texas, with operations in North America, Europe and Africa. The Company operates in three segments: North America E&P segment, which explores for, produces and markets crude oil and condensate, NGLs and natural gas in North America; International E&P segment, which explores for, produces and markets crude oil and condensate, NGLs and natural gas outside of North America and produces and markets products manufactured from natural gas, such as LNG and methanol, in Egypt and Oil Sands Mining segment, which mines, extracts and transports bitumen from oil sands deposits in Alberta, Canada, and upgrades the bitumen to produce and market synthetic crude oil and vacuum gas oil. It has production operations in the United States, Egypt, Canada, the United Kingdom and Libya.
Shares of Staples, Inc. (NASDAQ:SPLS), declined -2.52% to $12.37, during its last trading session.
Staples issued a statement in response to the European Commission’s declarement of a Phase II review of the Office Depot acquisition.
“We continue to work cooperatively with the European Commission regarding the acquisition of Office Depot,” said Ron Sargent, Chief Executive Officer, Staples, Inc. “The transaction would enable Staples to better serve customers around the world and to compete in a rapidly evolving global marketplace.”
Regulators in Australia, New Zealand and China have approved the transaction. Staples continues to work with regulatory authorities in the European Union, the United States and Canada.
Staples, Inc. is a provider of products and services that serve the needs of business customers and consumers. The Company offers a selection of products, such as Websites and mobile platforms, retail and online shopping and a range of copy and print and technology services.
Finally, Horizon Pharma PLC (NASDAQ:HZNP), ended its last trade with -4.23% loss, and closed at $22.78.
Depomed, Inc. (DEPO) (“Depomed” or the “Company”) recently issued the following statement regarding a report by Institutional Shareholder Services’ (“ISS”) on Horizon Pharma plc’s (HZNP) (“Horizon”) solicitation to call two special meetings of Depomed’s shareholders (the “Special Meetings”).
The ISS recommendation relates only to calling the Special Meetings, and ISS has not made any recommendation regarding Horizon’s proposal concerning directors or its exchange offer. In its report ISS states, “…ISS explicitly reserves judgment on the advisability of Horizon’s offer until shareholders have the benefit of additional information about the Nucynta relaunch, and are presented with the opportunity to vote on that question directly.”
The ISS recommendation does not change the fact that we believe Horizon’s offer does not reflect the value inherent in Depomed’s business nor Depomed’s compelling prospects for long-term growth and value creation, and therefore is not in the best interests of shareholders. ISS also notes the decline in value of Horizon’s offer in its report, “There is also the consideration that Horizon’s all-share offer has declined by about a third in market value since the offer was made public, and no longer represents a premium to the undisturbed price (or, for that matter, Depomed’s current trading price).”
As declared on September 14, 2015, Depomed’s Board of Directors, after careful consideration and in consultation with its financial and legal advisors, unanimously determined to recommend that Depomed shareholders reject Horizon’s unsolicited exchange offer.
Horizon Pharma plc, formerly Vidara Therapeutics International Public Limited Company, is a specialty biopharmaceutical company focused on identifying, developing, acquiring or in-licensing and commercializing differentiated products that address unmet medical needs.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified with such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
